# Dong-A ST

Source: https://onco.cc/companies/dong-a-st/  
OnCo record `dong-a-st` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Dong-A ST is a Seoul pharmaceutical company, the prescription-medicine arm of one of Korea's oldest drug groups, which sponsors phase 3 cancer trials including biosimilars and supportive-care products.

## Summary

Dong-A ST Co., Ltd. was formed in 2013 when the Dong-A group split its prescription business from its consumer arm. It develops and markets prescription medicines in Korea and abroad, including oncology supportive-care products, a pegylated G-CSF and biosimilars developed with partners, and it acts as lead sponsor of phase 3 cancer trials registered on ClinicalTrials.gov.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Dong-A ST Co., Ltd.; Dong-A Socio Holdings
- Tags: ctgov-sponsor
- HQ: Seoul
- Type: pharma
- Website: https://www.donga-st.com

## Sources

- Official website: https://www.donga-st.com
- ClinicalTrials.gov: trials led by Dong-A ST Co., Ltd.: https://clinicaltrials.gov/search?lead=Dong-A%20ST%20Co.%2C%20Ltd.
- Wikidata: https://www.wikidata.org/wiki/Q110114773

## Connected records

- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/dong-a-st.json